Who
Steven R. Altman
Director
Company insider
Files Form 4 as: Director, DexCom; Director, Ubiquiti; Vice Chairman, Qualcomm; Director, Amylin Pharmaceuticals.
In numbers
- Trades disclosed
- 1,109
- Buys
- 4
- Sells
- 142
- Bought
- $2.9M
- Sold
- $331.4M
- Companies
- 4
- Companies where not an officer
- 3
- First trade
- 14 Dec 2005
- Last trade
- 28 May 2026
- Last filed
- 1 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 28 May 2026filed 1 Jun 2026 | DXCM DexComMedical Devices | SEC FORM 4 Code A | —5,565 at $0.00 | filing |
| 28 May 2026filed 1 Jun 2026 | DXCM DexComMedical Devices | SEC FORM 4 Code A | —5,565 at $0.00 | filing |
| 8 May 2026filed 11 May 2026 | DXCM DexComMedical Devices | SEC FORM 4 Code G | —5,037 at $0.00 | filing |
| 8 May 2026filed 11 May 2026 | DXCM DexComMedical Devices | SEC FORM 4 Code G | —5,037 at $0.00 | filing |
| 8 May 2026filed 11 May 2026 | DXCM DexComMedical Devices | SEC FORM 4 Code G | —5,037 at $0.00 | filing |
| 8 May 2026filed 11 May 2026 | DXCM DexComMedical Devices | SEC FORM 4 Code G | —5,037 at $0.00 | filing |
| 8 May 2025filed 12 May 2025 | DXCM DexComMedical Devices | SEC FORM 4 Code G | —2,613 at $0.00 | filing |
| 8 May 2025filed 12 May 2025 | DXCM DexComMedical Devices | SEC FORM 4 Code G | —2,613 at $0.00 | filing |
| 8 May 2025filed 12 May 2025 | DXCM DexComMedical Devices | SEC FORM 4 Code A | —5,037 at $0.00 | filing |
| 22 May 2024filed 24 May 2024 | DXCM DexComMedical Devices | SEC FORM 4 Code A | —2,613 at $0.00 | filing |
| 18 May 2024filed 21 May 2024 | DXCM DexComMedical Devices | SEC FORM 4 Code G | —2,885 at $0.00 | filing |
| 18 May 2024filed 21 May 2024 | DXCM DexComMedical Devices | SEC FORM 4 Code G | —2,885 at $0.00 | filing |
| 16 Jan 2024filed 17 Jan 2024 | DXCM DexComMedical Devices | SEC FORM 4 Sold | $56K460 at $121.97 | filing |
| 16 Jan 2024filed 17 Jan 2024 | DXCM DexComMedical Devices | SEC FORM 4 Sold | $137K1,108 at $123.24 | filing |
| 15 Dec 2023filed 18 Dec 2023 | DXCM DexComMedical Devices | SEC FORM 4 Sold | $246K2,000 at $122.77 | filing |
| 12 Dec 2023filed 13 Dec 2023 | DXCM DexComMedical Devices | SEC FORM 4 Sold | $360K3,000 at $120.00 | filing |
| 15 Nov 2023filed 15 Nov 2023 | DXCM DexComMedical Devices | SEC FORM 4 Sold | $101K1,000 at $101.26 | filing |
| 16 Oct 2023filed 17 Oct 2023 | DXCM DexComMedical Devices | SEC FORM 4 Sold | $78K1,000 at $77.58 | filing |
| 15 Sep 2023filed 19 Sep 2023 | DXCM DexComMedical Devices | SEC FORM 4 Sold | $102K1,000 at $101.50 | filing |
| 18 May 2023filed 22 May 2023 | DXCM DexComMedical Devices | SEC FORM 4 Code A | —2,885 at $0.00 | filing |
The newest 500 lines are listed; the numbers count every line.
News
175,855 Qualcomm Incorporated $QCOM Shares Purchased by Vest Financial LLCQCOM · dailypolitical.com · 22 Oct 2026Insider Selling: Qualcomm (NASDAQ:QCOM) EVP Sells 2,500 Shares of StockQCOM · themarketsdaily.com · 21 Oct 2026Qualcomm (NASDAQ:QCOM) Shares Climb 1.3% on Analyst UpgradeQCOM · dailypolitical.com · 20 Oct 2026Vontobel Holding Ltd. Sells 14,970 Shares of DexCom, Inc. $DXCMDXCM · dailypolitical.com · 20 Oct 2026
0 headlines in the last 90 days name Steven R. Altman; 4 articles from the last 14 days about the 3 companies they traded most, at most three about any one of them.